login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
PHARMING GROUP NV - ADR (PHAR) Stock News
USA
- NASDAQ:PHAR -
US71716E1055
-
ADR
13.6
USD
-1.21 (-8.17%)
Last: 10/24/2025, 8:00:00 PM
15.22
USD
+1.62 (+11.91%)
After Hours:
10/17/2025, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
PHAR Latest News, Press Relases and Analysis
All
Press Releases
a month ago - By: Benzinga
- Mentions:
LGCY
VNET
KC
DRIO
...
Concentrix Posts Downbeat Earnings, Joins Legacy Education, Kingsoft Cloud And Other Big Stocks Moving Lower In Friday's Pre-Market Session
a month ago - By: Benzinga
- Mentions:
BLMZ
NITO
MRM
WGRX
...
Why Top KingWin Shares Are Trading Higher By 87%; Here Are 20 Stocks Moving Premarket
a month ago - By: Zacks Investment Research
- Mentions:
ZTS
CRMD
KNSA
Zoetis Gains CVMP Backing for Portela, Eyes EU Approval in Cat OA Pain
2 months ago - By: Zacks Investment Research
- Mentions:
RARE
CRMD
KNSA
RARE Reports Positive Long-Term Data From Metabolic Disorder Study
2 months ago - By: Zacks Investment Research
- Mentions:
CRMD
KNSA
IMVT
IMVT Stock Up 11% on Upbeat Batoclimab Hyperthyroidism Study Results
3 months ago - By: Zacks Investment Research
- Mentions:
ROKU
ARI
ASC
META
New Strong Buy Stocks for August 1st
2 months ago - By: Zacks Investment Research
- Mentions:
CRMD
EDIT
KNSA
Editas Nominates EDIT-401 as Lead In Vivo Therapy for High Cholesterol
2 months ago - By: Zacks Investment Research
- Mentions:
ORCL
CBRE
FAST
TMO
...
Beat the Market the Zacks Way: Oracle, Intellia, Pharming Group in Focus
2 months ago - By: Zacks Investment Research
- Mentions:
CRMD
KNSA
OTLK
OTLK Stock Crashes 54% as FDA Issues Second CRL for Eye Disease Drug
2 months ago - By: Zacks Investment Research
- Mentions:
CPRX
CRMD
KNSA
Catalyst Pharmaceuticals Settles Firdapse Patent Litigation With Lupin
2 months ago - By: Zacks Investment Research
Wall Street Analysts See a 142.26% Upside in Pharming Group (PHAR): Can the Stock Really Move This High?
a year ago - By: InvestorPlace
PHAR Stock Earnings: Pharming Reported Results for Q1 2024
6 months ago - By: Yahoo Finance
- Mentions:
RY
RY.CA
DHI
CMG
Pharming announces positive recommendation from NICE for Joenja
6 months ago - By: Yahoo Finance
- Mentions:
ROK
WOR
POWL
March home sales slowed in a lethargic opening to the spring buying season
a year ago - By: InvestorPlace
- Mentions:
IMNN
JTAI
ENVB
ISPO
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
2 years ago - By: Seeking Alpha
Pharming Group issues full-year 2023 guidance (NASDAQ:PHAR)
Please enable JavaScript to continue using this application.